FDA
approval
· 2022-03-03
FDA Approved: MICROGESTIN 24 FE — Supplemental Application (Mayne Pharma Inc.)
Summary
FDA approved a supplemental application for MICROGESTIN 24 FE (norethindrone acetate/ethinyl estradiol and ferrous fumarate) from Mayne Pharma Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MICROGESTIN 24 FE (NORETHINDRONE ACETATE/ETHINYL ESTRADIOL AND FERROUS FUMARATE)